{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:27:04Z","timestamp":1792168024484,"version":"4.4.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006359","name":"Blekinge Institute of Technology","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006359","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Previous literature indicate retinal hyperspectral imaging as a non-invasive method with the potential for identifying amyloid-beta (A\u03b2) protein deposits. Current diagnostic methods, such as cerebrospinal fluid analysis or positron emission tomography, are costly, invasive, and non-scalable. Hyperspectral imaging offers a potentially accessible alternative for early detection of Alzheimer\u2019s disease. The aim of this study is to investigate the potential of retinal hyperspectral imaging in identifying A\u03b2-positive patients within a clinical cohort from a memory clinic.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A prospective cross-sectional cohort study was conducted between January 2023 and May 2024 at a single memory clinic in Sweden. The study recruited 57 patients (35 A\u03b2-positive and 22 A\u03b2-negative) who underwent lumbar puncture as part of their diagnostic workup for cognitive complaints. Retinal hyperspectral images were captured from all participants at the time of their lumbar puncture and again 2\u20134 weeks later. Data was collected from five anatomical regions of the retina (Superior 1, Superior 2, Inferior 1, Inferior 2, and the center of the Fovea).The main outcome was the A\u03b2 status (A\u03b2-positive or A\u03b2-negative). Catboost machine learning models were trained on hyperspectral imaging data to predict A\u03b2 status. A nested cross-validation approach was used to train and evaluate classification models. Performance metrics included area under the curve (AUC), accuracy, sensitivity, and specificity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The best-performing model used the combination of regions Superior 1, Superior 2, and center of the fovea, achieving a mean AUC of 0.77 (0.05), mean accuracy of 0.66 (0.03), and mean sensitivity of 0.73 (0.13) and mean specificity of 0.55 (0.12). Performance was consistent across outer folds. Models using all five regions or less-informative combinations yielded lower and more variable results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Retinal hyperspectral imaging combined with the Catboost algorithm demonstrated significant potential as a non-invasive biomarker for detecting Alzheimer\u2019s disease in a consecutive clinical cohort. Further studies should validate these findings in larger, more diverse populations and explore the integration of hyperspectral imaging with other diagnostic modalities. Limited sample size and imaging constraints highlight the need for validation in diverse clinical settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>ClinicalTrials.gov, ID: NCT05604183 (registration date: 2022-10-27).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13195-025-01887-4","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T12:13:20Z","timestamp":1761653600000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Hyperspectral retinal imaging to detect Alzheimer\u2019s disease in a memory clinic setting"],"prefix":"10.1186","volume":"17","author":[{"given":"Ana Luiza","family":"Dallora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pushpa Priyanka","family":"Palesetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Guenot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"Selvander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan Sanmartin","family":"Berglund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Behrens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"key":"1887_CR1","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CR Jack","year":"2024","unstructured":"Jack CR, Andrews JS, Beach TG, Buracchio T, Dunn B, Graf A, et al. Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association workgroup. Alzheimers Dement. 2024;20:5143\u201369. https:\/\/doi.org\/10.1002\/alz.13859.","journal-title":"Alzheimers Dement"},{"key":"1887_CR2","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/S1474-4422(21)00066-1","volume":"20","author":"B Dubois","year":"2021","unstructured":"Dubois B, Villain N, Frisoni GB, Rabinovici GD, Sabbagh M, Cappa S, et al. Clinical diagnosis of Alzheimer\u2019s disease: recommendations of the international working group. Lancet Neurol. 2021;20:484\u201396. https:\/\/doi.org\/10.1016\/S1474-4422(21)00066-1.","journal-title":"Lancet Neurol"},{"key":"1887_CR3","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/S1474-4422(20)30440-3","volume":"20","author":"J Graff-Radford","year":"2021","unstructured":"Graff-Radford J, Yong KXX, Apostolova LG, Bouwman FH, Carrillo M, Dickerson BC, et al. New insights into atypical Alzheimer\u2019s disease in the era of biomarkers. Lancet Neurol. 2021;20:222\u201334. https:\/\/doi.org\/10.1016\/S1474-4422(20)30440-3.","journal-title":"Lancet Neurol"},{"key":"1887_CR4","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1097\/NEN.0b013e31824b211b","volume":"71","author":"TG Beach","year":"2012","unstructured":"Beach TG, Monsell SE, Phillips LE, Kukull W. Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005\u20132010. J Neuropathol Exp Neurol. 2012;71:266\u201373. https:\/\/doi.org\/10.1097\/NEN.0b013e31824b211b.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1887_CR5","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1097\/WAD.0b013e3181a6bebc","volume":"23","author":"A Bradford","year":"2009","unstructured":"Bradford A, Kunik ME, Schulz P, Williams SP, Singh H. Missed and delayed diagnosis of dementia in primary care: prevalence and contributing factors. Alzheimer Dis Assoc Disord. 2009;23:306\u201314. https:\/\/doi.org\/10.1097\/WAD.0b013e3181a6bebc.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"1887_CR6","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16049","volume":"31","author":"R Perneczky","year":"2024","unstructured":"Perneczky R, Dom G, Chan A, Falkai P, Bassetti C. Anti-amyloid antibody treatments for Alzheimer\u2019s disease. Eur J Neurol. 2024;31:e16049. https:\/\/doi.org\/10.1111\/ene.16049.","journal-title":"Eur J Neurol"},{"key":"1887_CR7","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","volume":"12","author":"VL Villemagne","year":"2013","unstructured":"Villemagne VL, Burnham S, Bourgeat P, Brown B, Ellis KA, Salvado O, et al. Amyloid \u03b2 deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer\u2019s disease: a prospective cohort study. Lancet Neurol. 2013;12:357\u201367. https:\/\/doi.org\/10.1016\/S1474-4422(13)70044-9.","journal-title":"Lancet Neurol"},{"key":"1887_CR8","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/s41591-021-01382-x","volume":"27","author":"O Hansson","year":"2021","unstructured":"Hansson O. Biomarkers for neurodegenerative diseases. Nat Med. 2021;27:954\u201363. https:\/\/doi.org\/10.1038\/s41591-021-01382-x.","journal-title":"Nat Med"},{"key":"1887_CR9","unstructured":"Behrens A. Measurements in Idiopathic Normal Pressure Hydrocephalus: Computerized neuropsychological test battery and intracranial pulse waves. Dissertation. Ume\u00e5: Ume\u00e5 University; 2014."},{"key":"1887_CR10","doi-asserted-by":"publisher","first-page":"5416","DOI":"10.1007\/s12035-018-1461-6","volume":"56","author":"S Chiquita","year":"2019","unstructured":"Chiquita S, Rodrigues-Neves AC, Baptista FI, Carecho R, Moreira PI, Castelo-Branco M, et al. The retina as a window or mirror of the brain changes detected in Alzheimer\u2019s disease: critical aspects to unravel. Mol Neurobiol. 2019;56:5416\u201335. https:\/\/doi.org\/10.1007\/s12035-018-1461-6.","journal-title":"Mol Neurobiol"},{"key":"1887_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-020-00715-1","volume":"12","author":"S Lemmens","year":"2020","unstructured":"Lemmens S, Van Craenendonck T, Van Eijgen J, De Groef L, Bruffaerts R, de Jesus DA, et al. Combination of snapshot hyperspectral retinal imaging and optical coherence tomography to identify Alzheimer\u2019s disease patients. Alzheimers Res Ther. 2020;12:144. https:\/\/doi.org\/10.1186\/s13195-020-00715-1.","journal-title":"Alzheimers Res Ther"},{"key":"1887_CR12","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.3233\/JAD-190868","volume":"73","author":"N Schultz","year":"2020","unstructured":"Schultz N, Byman E, Netherlands Brain Bank, Wennstr\u00f6m M. Levels of retinal amyloid-\u03b2 correlate with levels of retinal IAPP and hippocampal amyloid-\u03b2 in neuropathologically evaluated individuals. J Alzheimers Dis. 2020;73:1201\u20139. https:\/\/doi.org\/10.3233\/JAD-190868.","journal-title":"J Alzheimers Dis"},{"key":"1887_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12242-1","volume":"10","author":"X Hadoux","year":"2019","unstructured":"Hadoux X, Hui F, Lim JKH, Masters CL, P\u00e9bay A, Chevalier S, et al. Non-invasive in vivo hyperspectral imaging of the retina for potential biomarker use in Alzheimer\u2019s disease. Nat Commun. 2019;10:4227. https:\/\/doi.org\/10.1038\/s41467-019-12242-1.","journal-title":"Nat Commun"},{"key":"1887_CR14","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.9.9.9","volume":"9","author":"S Lemmens","year":"2020","unstructured":"Lemmens S, Van Eijgen J, Van Keer K, Jacob J, Moylett S, De Groef L, et al. Hyperspectral imaging and the retina: worth the wave? Transl Vis Sci Technol. 2020;9:9. https:\/\/doi.org\/10.1167\/tvst.9.9.9.","journal-title":"Transl Vis Sci Technol"},{"key":"1887_CR15","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.trci.2019.09.006","volume":"5","author":"SM Sharafi","year":"2019","unstructured":"Sharafi SM, Sylvestre J-P, Chevrefils C, Soucy J-P, Beaulieu S, Pascoal TA, et al. Vascular retinal biomarkers improves the detection of the likely cerebral amyloid status from hyperspectral retinal images. Alzheimers Dement. 2019;5:610\u20137. https:\/\/doi.org\/10.1016\/j.trci.2019.09.006.","journal-title":"Alzheimers Dement"},{"key":"1887_CR16","doi-asserted-by":"publisher","DOI":"10.1364\/opticaopen.25047800.v1","author":"D Guenot","year":"2024","unstructured":"Guenot D, Alexander J, Selvander M. A novel concept of compact, snapshot hyperspectral camera for ophthalmology. Optica Open. 2024. https:\/\/doi.org\/10.1364\/opticaopen.25047800.v1.","journal-title":"Optica Open"},{"key":"1887_CR17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.5093\/ejpalc2018a5","volume":"10","author":"JF Salgado","year":"2018","unstructured":"Salgado JF. Transforming the area under the normal curve (AUC) into cohen\u2019s d, pearson\u2019s r pb, odds-ratio, and natural log odds-ratio: two conversion tables. Eur J Psychol Appl Leg Context. 2018;10:35\u201347. https:\/\/doi.org\/10.5093\/ejpalc2018a5.","journal-title":"Eur J Psychol Appl Leg Context"},{"key":"1887_CR18","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine ZS, Phillips NA, B\u00e9dirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal cognitive Assessment, moca: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695\u20139. https:\/\/doi.org\/10.1111\/j.1532-5415.2005.53221.x.","journal-title":"J Am Geriatr Soc"},{"key":"1887_CR19","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/j.1600-0404.2009.01312.x","volume":"121","author":"R Astrand","year":"2010","unstructured":"Astrand R, Rolstad S, Wallin A. Cognitive impairment questionnaire (CIMP-QUEST): reported topographic symptoms in MCI and dementia. Acta Neurol Scand. 2010;121:384\u201391. https:\/\/doi.org\/10.1111\/j.1600-0404.2009.01312.x.","journal-title":"Acta Neurol Scand"},{"key":"1887_CR20","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1080\/08039480600937066","volume":"60","author":"A K\u00f8rner","year":"2006","unstructured":"K\u00f8rner A, Lauritzen L, Abelskov K, Gulmann N, Marie Brodersen A, Wedervang-Jensen T, et al. The geriatric depression scale and the Cornell scale for depression in dementia. A validity study. Nord J Psychiatry. 2006;60:360\u20134. https:\/\/doi.org\/10.1080\/08039480600937066.","journal-title":"Nord J Psychiatry"},{"key":"1887_CR21","doi-asserted-by":"publisher","DOI":"10.2196\/23589","volume":"6","author":"A Behrens","year":"2022","unstructured":"Behrens A, Berglund JS, Anderberg P. Cognit automated tablet computer cognitive testing in patients with mild cognitive impairment: feasibility study. JMIR Form Res. 2022;6:e23589. https:\/\/doi.org\/10.2196\/23589.","journal-title":"JMIR Form Res"},{"key":"1887_CR22","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1179\/174313110x12771950995716","volume":"58","author":"PWT Yuen","year":"2010","unstructured":"Yuen PWT, Richardson M. An introduction to hyperspectral imaging and its application for security, surveillance and target acquisition. Imaging Sci J. 2010;58:241\u201353. https:\/\/doi.org\/10.1179\/174313110x12771950995716.","journal-title":"Imaging Sci J"},{"issue":"6","key":"1887_CR23","doi-asserted-by":"publisher","DOI":"10.1088\/2040-8986\/aab74c","volume":"20","author":"LE MacKenzie","year":"2018","unstructured":"MacKenzie LE, Harvey AR. Oximetry using multispectral imaging: theory and application. J Opt. 2018;20(6):063501. https:\/\/doi.org\/10.1088\/2040-8986\/aab74c.","journal-title":"J Opt"},{"key":"1887_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2019.04.001","volume":"70","author":"E Stef\u00e1nsson","year":"2019","unstructured":"Stef\u00e1nsson E, Olafsdottir OB, Eliasdottir TS, Vehmeijer W, Einarsdottir AB, Bek T, et al. Retinal oximetry: metabolic imaging for diseases of the retina and brain. Prog Retin Eye Res. 2019;70:1\u201322. https:\/\/doi.org\/10.1016\/j.preteyeres.2019.04.001.","journal-title":"Prog Retin Eye Res"},{"key":"1887_CR25","unstructured":"Liudmila Prokhorenkova G, Gusev A, Vorobev AV, Dorogush, Andrey Gulin. CatBoost: unbiased boosting with categorical features. NIPS\u201918: Proceedings of the 32nd International Conference on Neural Information Processing Systems, United States: Curran Associates Inc.; 2018."},{"key":"1887_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/1929137","volume":"2021","author":"F Zhou","year":"2021","unstructured":"Zhou F, Pan H, Gao Z, Huang X, Qian G, Zhu Y, et al. Fire prediction based on catboost algorithm. Math Probl Eng. 2021;2021:1\u20139. https:\/\/doi.org\/10.1155\/2021\/1929137.","journal-title":"Math Probl Eng"},{"key":"1887_CR27","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/978-981-99-7814-4_19","volume-title":"Data science and applications","author":"P Lalwani","year":"2024","unstructured":"Lalwani P, Ramasamy G. Hybrid principal component analysis using boosting classification techniques: categorical boosting. In: Data science and applications. Singapore: Springer Nature Singapore; 2024. p. 229\u201342. https:\/\/doi.org\/10.1007\/978-981-99-7814-4_19."},{"key":"1887_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2023.106707","volume":"156","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, Guo X, Yang Y, Wang H, Liao K, Qin J. Phonocardiogram transfer learning-based catboost model for diastolic dysfunction identification using multiple domain-specific deep feature fusion. Comput Biol Med. 2023;156:106707. https:\/\/doi.org\/10.1016\/j.compbiomed.2023.106707.","journal-title":"Comput Biol Med"},{"key":"1887_CR29","first-page":"212","volume":"20","author":"L Kurlowicz","year":"1999","unstructured":"Kurlowicz L. The geriatric depression scale (GDS). Geriatr Nurs. 1999;20:212\u20133.","journal-title":"Geriatr Nurs"},{"key":"1887_CR30","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/ana.24548","volume":"79","author":"C La Morgia","year":"2016","unstructured":"La Morgia C, Ross-Cisneros FN, Koronyo Y, Hannibal J, Gallassi R, Cantalupo G, et al. Melanopsin retinal ganglion cell loss in alzheimer disease: mRGC loss in AD. Ann Neurol. 2016;79:90\u2013109. https:\/\/doi.org\/10.1002\/ana.24548.","journal-title":"Ann Neurol"},{"key":"1887_CR31","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1001\/jama.2024.13855","volume":"332","author":"S Palmqvist","year":"2024","unstructured":"Palmqvist S, Tideman P, Mattsson-Carlgren N, Schindler SE, Smith R, Ossenkoppele R, et al. Blood biomarkers to detect Alzheimer disease in primary care and secondary care. JAMA. 2024;332:1245\u201357. https:\/\/doi.org\/10.1001\/jama.2024.13855.","journal-title":"JAMA"},{"key":"1887_CR32","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1093\/brain\/awac333","volume":"146","author":"S Janelidze","year":"2023","unstructured":"Janelidze S, Bali D, Ashton NJ, Barth\u00e9lemy NR, Vanbrabant J, Stoops E, et al. Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer\u2019s disease. Brain. 2023;146:1592\u2013601. https:\/\/doi.org\/10.1093\/brain\/awac333.","journal-title":"Brain"},{"key":"1887_CR33","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1002\/alz.12787","volume":"19","author":"A Pichet Binette","year":"2023","unstructured":"Pichet Binette A, Janelidze S, Cullen N, Dage JL, Bateman RJ, Zetterberg H, et al. Confounding factors of Alzheimer\u2019s disease plasma biomarkers and their impact on clinical performance. Alzheimers Dement. 2023;19:1403\u201314. https:\/\/doi.org\/10.1002\/alz.12787.","journal-title":"Alzheimers Dement"},{"key":"1887_CR34","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1001\/jamaneurol.2023.0199","volume":"80","author":"S Janelidze","year":"2023","unstructured":"Janelidze S, Barth\u00e9lemy NR, He Y, Bateman RJ, Hansson O. Mitigating the associations of kidney dysfunction with blood biomarkers of Alzheimer disease by using phosphorylated Tau to total Tau ratios. JAMA Neurol. 2023;80:516\u201322. https:\/\/doi.org\/10.1001\/jamaneurol.2023.0199.","journal-title":"JAMA Neurol"},{"key":"1887_CR35","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1002\/alz.13518","volume":"20","author":"WS Brum","year":"2024","unstructured":"Brum WS, Ashton NJ, Simr\u00e9n J, di Molfetta G, Karikari TK, Benedet AL, et al. Biological variation estimates of Alzheimer\u2019s disease plasma biomarkers in healthy individuals. Alzheimers Dement. 2024;20:1284\u201397. https:\/\/doi.org\/10.1002\/alz.13518.","journal-title":"Alzheimers Dement"},{"key":"1887_CR36","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/s43587-024-00599-y","volume":"4","author":"G Salvad\u00f3","year":"2024","unstructured":"Salvad\u00f3 G, Horie K, Barth\u00e9lemy NR, Vogel JW, Pichet Binette A, Chen CD, et al. Disease staging of Alzheimer\u2019s disease using a CSF-based biomarker model. Nat Aging. 2024;4:694\u2013708. https:\/\/doi.org\/10.1038\/s43587-024-00599-y.","journal-title":"Nat Aging"},{"key":"1887_CR37","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1002\/ana.24182","volume":"75","author":"I Bodis-Wollner","year":"2014","unstructured":"Bodis-Wollner I, Kozlowski PB, Glazman S, Miri S. \u03b1-Synuclein in the inner retina in Parkinson disease. Ann Neurol. 2014;75:964\u20136. https:\/\/doi.org\/10.1002\/ana.24182.","journal-title":"Ann Neurol"},{"key":"1887_CR38","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.neulet.2014.04.027","volume":"571","author":"TG Beach","year":"2014","unstructured":"Beach TG, Carew J, Serrano G, Adler CH, Shill HA, Sue LI, et al. Phosphorylated \u03b1-synuclein-immunoreactive retinal neuronal elements in Parkinson\u2019s disease subjects. Neurosci Lett. 2014;571:34\u20138. https:\/\/doi.org\/10.1016\/j.neulet.2014.04.027.","journal-title":"Neurosci Lett"},{"key":"1887_CR39","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1002\/mds.27392","volume":"33","author":"I Ortu\u00f1o-Lizar\u00e1n","year":"2018","unstructured":"Ortu\u00f1o-Lizar\u00e1n I, Beach TG, Serrano GE, Walker DG, Adler CH, Cuenca N. Phosphorylated \u03b1-synuclein in the retina is a biomarker of Parkinson\u2019s disease pathology severity. Mov Disord. 2018;33:1315\u201324. https:\/\/doi.org\/10.1002\/mds.27392.","journal-title":"Mov Disord"},{"key":"1887_CR40","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1007\/s11357-020-00252-7","volume":"42","author":"C Czak\u00f3","year":"2020","unstructured":"Czak\u00f3 C, Kov\u00e1cs T, Ungvari Z, Csiszar A, Yabluchanskiy A, Conley S, et al. Retinal biomarkers for Alzheimer\u2019s disease and vascular cognitive impairment and dementia (VCID): implication for early diagnosis and prognosis. GeroScience. 2020;42:1499\u2013525. https:\/\/doi.org\/10.1007\/s11357-020-00252-7.","journal-title":"GeroScience"},{"key":"1887_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.70181","volume":"17","author":"A Behrens","year":"2025","unstructured":"Behrens A, Anderberg P, Berglund JS, Cianchetta-Sivoriceruti M, Dallora AL. Blood biomarkers for Alzheimer\u2019s disease: reliable change and impacts of renal and blood\u2013brain barrier function. Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring. 2025;17:e70181. https:\/\/doi.org\/10.1002\/dad2.70181.","journal-title":"Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"issue":"12","key":"1887_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14121285","volume":"14","author":"C-Y Wang","year":"2024","unstructured":"Wang C-Y, Nguyen H-T, Fan W-S, Lue J-H, Saenprasarn P, Chen M-M, et al. Glaucoma detection through a novel hyperspectral imaging band selection and vision transformer integration. Diagnostics. 2024;14(12):1285. https:\/\/doi.org\/10.3390\/diagnostics14121285.","journal-title":"Diagnostics"},{"issue":"1","key":"1887_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-024-01868-y","volume":"12","author":"X Du","year":"2024","unstructured":"Du X, Park J, Zhao R, Smith RT, Koronyo Y, Koronyo-Hamaoui M, et al. Hyperspectral retinal imaging in Alzheimer\u2019s disease and age-related macular degeneration: a review. Acta Neuropathol Commun. 2024;12(1):157. https:\/\/doi.org\/10.1186\/s40478-024-01868-y.","journal-title":"Acta Neuropathol Commun"},{"key":"1887_CR44","doi-asserted-by":"publisher","DOI":"10.1136\/bmjophth-2023-001628","volume":"9","author":"L von der Emde","year":"2024","unstructured":"von der Emde L, Rennen GC, Vaisband M, Hasenauer J, Liegl R, Fleckenstein M, et al. Impact of lens autofluorescence and opacification on retinal imaging. BMJ Open Ophthalmol. 2024;9:e001628. https:\/\/doi.org\/10.1136\/bmjophth-2023-001628.","journal-title":"BMJ Open Ophthalmol"},{"issue":"8","key":"1887_CR45","first-page":"1306","volume":"29","author":"PA Sample","year":"1988","unstructured":"Sample PA, Esterson FD, Weinreb RN, Boynton RM. The aging lens: in vivo assessment of light absorption in 84 human eyes. Invest Ophthalmol Vis Sci. 1988;29(8):1306\u201311.","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01887-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-025-01887-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01887-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:04:22Z","timestamp":1761696262000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-025-01887-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1887"],"URL":"https:\/\/doi.org\/10.1186\/s13195-025-01887-4","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,28]]},"assertion":[{"value":"30 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for the study was obtained from the Ethical Review Board in Gothenburg (Dnr 2022-05804-01), and all procedures were carried out in compliance with the Declaration of Helsinki. Written informed consent was obtained from all participants prior to inclusion. All collected data were anonymized and securely stored in accordance with the data protection protocols of the Blekinge Institute of Technology.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"232"}}